Glaxosmithkline | GSK - 普通股股本

金融业

GBP

GBP 82.34B

现金及等价物

GBP 3.3B

GBP 3.47B

GBP 23.59B

GBP 28.82B

GBP 17.75B

股息收益率

GBP 4.47

GBP 2.3B

GBP 4.75B

GBP 69.4K

EPS每股收益

GBP 0.62

股本和储备

GBP 22.06B

GBP 8.75B

债务利息支出

GBP 177.95M

GBP 26M

GBP 19.82B

GBP 106.11B

GBP 846.06M

GBP 9.17B

GBP 2.3B

普通股股本

GBP 4.08B

11.66

GBP 2.46B

GBP 10.09B

销售和管理费用

GBP 3.56B

GBP 6.12B

贸易债权人

GBP 20.72B

应收帐款人

GBP 10.45B

	普通股股本	更改		日
AbbVie	USD 1.77B		1.75B	2025-06
Amgen	USD 540M		1000K	2026-03
AstraZeneca	USD 1.55B		73K	2026-03
Aurora Cannabis	CAD 56.71M		134.13K	2025-12
Bausch Health Companies	USD 373.46M		2.93M	2026-03
Bristol-Myers Squibb	USD 2.04B		1.74B	2025-09
Canopy Growth	CAD 368.28M		35.9M	2025-12
Corcept Therapeutics	USD 107.33M		1.36M	2026-03
Drreddys Laboratories	INR 832.57M		53K	2025-12
Eli Lilly	USD 943.5M		3.33M	2026-03
GlaxoSmithKline	GBP 4.05B		20.6M	2026-03
Glaxosmithkline	GBP 4.08B		49.43M	2025-12
J&J	USD 2.41B		1.74M	2025-12
Merck	USD 2.47B		12.72M	2025-12
Novartis	USD 1.91B		60K	2026-03
Pacira	USD 39.31M		1.81M	2026-03
Perrigo	USD 138.1M		500K	2026-03
Pfizer	USD 5.7B		13M	2026-03
Phibro Animal Health	USD 40.48M		0	2025-12
Prestige Brands	USD 47.32M		765K	2025-12
Roche Holding	CHF 795.62M		699.54K	2025-12
Sanofi	EUR 1.21B		8.25M	2026-03
Supernus Pharmaceuticals	USD 58.04M		582K	2026-03
Takeda	JPY 1.58B		241K	2026-03
Teva Pharmaceutical Industries	USD 1.16B		16.72M	2026-03
Zoetis	USD 420.35M		4.58M	2026-03